Found 8 matching trials
Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban
PHASE2This study will evaluate the establishment of anticoagulation ("re-anticoag...
Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban
PHASE1PER977 monotherapy and co-administration following 60 mg edoxaban will have...
Location
Duke Clinical Research, Unit 200
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
PHASE2A randomized, double-blind, placebo-controlled study to evaluate the effica...
Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT
PHASE2This study is a randomized, single-blind, placebo-controlled study to asses...
Location
Frontage Clinical Services Inc.
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin
PHASE1Normal subjects will receive unfractionated heparin followed by a single do...
An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male Subjects
PHASE1This is an open-label, single-dose, non-randomized study in healthy male su...
Location
Worldwide Clinical Trials Early Phase Services
PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin
PHASE1PER977 administration following a single dose of enoxaparin...
Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT
PHASE2This study is a randomized, single-blind, placebo-controlled study to asses...
Location
Frontage Clinical Services Inc.